• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan

tetano

Editor, Senior Moderator
Nat Commun


. 2021 Jul 6;12(1):4144.
doi: 10.1038/s41467-021-24230-5.
Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan


Cesheng Li[SUP] #[/SUP][SUP] 1 [/SUP], Ding Yu[SUP] #[/SUP][SUP] 2 3 [/SUP], Xiao Wu[SUP] 1 [/SUP], Hong Liang[SUP] 2 3 [/SUP], Zhijun Zhou[SUP] 1 [/SUP], Yong Xie[SUP] 1 3 [/SUP], Taojing Li[SUP] 3 [/SUP], Junzheng Wu[SUP] 2 [/SUP], Fengping Lu[SUP] 1 [/SUP], Lu Feng[SUP] 1 [/SUP], Min Mao[SUP] 1 [/SUP], Lianzhen Lin[SUP] 1 [/SUP], Huanhuan Guo[SUP] 1 [/SUP], Shenglan Yue[SUP] 1 [/SUP], Feifei Wang[SUP] 1 [/SUP], Yan Peng[SUP] 1 [/SUP], Yong Hu[SUP] 1 [/SUP], Zejun Wang[SUP] 4 [/SUP], Jianhong Yu[SUP] 1 [/SUP], Yong Zhang[SUP] 3 [/SUP], Jia Lu[SUP] 4 [/SUP], Haoran Ning[SUP] 1 [/SUP], Huichuan Yang[SUP] 5 [/SUP], Daoxing Fu[SUP] 3 [/SUP], Yanlin He[SUP] 1 3 [/SUP], Dongbo Zhou[SUP] 3 [/SUP], Tao Du[SUP] 3 [/SUP], Kai Duan[SUP] 4 [/SUP], Demei Dong[SUP] 3 [/SUP], Kun Deng[SUP] 1 [/SUP], Xia Zou[SUP] 1 [/SUP], Ya Zhang[SUP] 1 [/SUP], Rong Zhou[SUP] 3 [/SUP], Yang Gao[SUP] 3 [/SUP], Xinxin Zhang[SUP] 6 [/SUP], Xiaoming Yang[SUP] 7 [/SUP]



Affiliations

Abstract

To investigate the duration of humoral immune response in convalescent coronavirus disease 2019 (COVID-19) patients, we conduct a 12-month longitudinal study through collecting a total of 1,782 plasma samples from 869 convalescent plasma donors in Wuhan, China and test specific antibody responses. The results show that positive rate of IgG antibody against receptor-binding domain of spike protein (RBD-IgG) to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the COVID-19 convalescent plasma donors exceeded 70% for 12 months post diagnosis. The level of RBD-IgG decreases with time, with the titer stabilizing at 64.3% of the initial level by the 9th month. Moreover, male plasma donors produce more RBD-IgG than female, and age of the patients positively correlates with the RBD-IgG titer. A strong positive correlation between RBD-IgG and neutralizing antibody titers is also identified. These results facilitate our understanding of SARS-CoV-2-induced immune memory to promote vaccine and therapy development.
 
Back
Top Bottom